These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 16575035

  • 1. Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine.
    Axelsson P, Thörn SE, Lövqvist A, Wattwil L, Wattwil M.
    Can J Anaesth; 2006 Apr; 53(4):370-4. PubMed ID: 16575035
    [Abstract] [Full Text] [Related]

  • 2. Betamethasone does not prevent nausea and vomiting induced by ipecacuanha.
    Axelsson P, Thörn SE, Wattwil M.
    Acta Anaesthesiol Scand; 2004 Nov; 48(10):1283-6. PubMed ID: 15504189
    [Abstract] [Full Text] [Related]

  • 3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG.
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [Abstract] [Full Text] [Related]

  • 4. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U, Drechsler S, Eggert J, Gosse H, Ukena D, Imhoff W, Faerber L.
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of pre-emptive metoclopramide infusion in alleviating pain, discomfort and nausea associated with nasogastric tube insertion: a randomised, double-blind, placebo-controlled trial.
    Ozucelik DN, Karaca MA, Sivri B.
    Int J Clin Pract; 2005 Dec; 59(12):1422-7. PubMed ID: 16351674
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pretreatment of patients requiring oral contrast abdominal computed tomography with antiemetics: a randomized controlled trial of efficacy.
    Garra G, Singer AJ, Bamber D, Chohan J, Troxell R, Thode HC.
    Ann Emerg Med; 2009 Apr; 53(4):528-33. PubMed ID: 18640743
    [Abstract] [Full Text] [Related]

  • 8. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G, Krzakowski M, Pawinski A, Lasota W, Rogowski W, Skoneczna I.
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [Abstract] [Full Text] [Related]

  • 9. Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection.
    Hauser RA, Isaacson S, Clinch T, Tigan/Apokyn Study Investigators.
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1171-6. PubMed ID: 25239603
    [Abstract] [Full Text] [Related]

  • 10. Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.
    Osoba D, Erlichman C, Willan AR, Levitt M, Pater JL.
    Clin Invest Med; 1986 Nov; 9(4):225-31. PubMed ID: 3542325
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Apomorphine (Apokyn) for advanced Parkinson's Disease.
    Med Lett Drugs Ther; 2005 Jan 17; 47(1200):7-8. PubMed ID: 15647705
    [Abstract] [Full Text] [Related]

  • 13. Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide.
    Bruera ED, Roca E, Cedaro L, Chacón R, Estévez R.
    Cancer Treat Rep; 1983 Apr 17; 67(4):381-3. PubMed ID: 6342770
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T, Sriswasdi C, Mongkonsritragoon W, Leelasiri A, Prayoonwiwat W.
    J Med Assoc Thai; 2002 Nov 17; 85(11):1156-63. PubMed ID: 12546311
    [Abstract] [Full Text] [Related]

  • 15. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T, Secen N, Povazan Dj, Sabo A, Popovic J, Bursac D, Kakas M, Zaric B, Milovancev A.
    J BUON; 2007 Nov 17; 12(2):245-52. PubMed ID: 17600880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Prophylaxis of nausea and vomiting after thyroid surgery: comparison of oral and intravenous dolasetron with intravenous droperidol and placebo].
    Danner K, Becker HG, Best B, Madler C.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul 17; 36(7):425-30. PubMed ID: 11496617
    [Abstract] [Full Text] [Related]

  • 18. [Nausea and vomiting in cytostatic therapy of melanoma patients with the use of metoclopramide and corticosteroid or ondansetron].
    Czeglédi F, Baki M.
    Orv Hetil; 1994 Oct 30; 135(44):2415-9. PubMed ID: 7970661
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, cross-over study comparing a levosulpiride-based and a metoclopramide-based combination in the prevention of ProMECE-CytaBOM-induced emesis.
    Sabbatini R, Federico M, Baldini L, Barbieri F, Maiolo MT, Silingardi V.
    Haematologica; 1995 Oct 30; 80(5):416-20. PubMed ID: 8566881
    [Abstract] [Full Text] [Related]

  • 20. Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial.
    Lajolo PP, de Camargo B, del Giglio A.
    Am J Clin Oncol; 2009 Feb 30; 32(1):23-6. PubMed ID: 19194119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.